BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maheswaran H, Barton P. Intensive case finding and isoniazid preventative therapy in HIV infected individuals in Africa: economic model and value of information analysis. PLoS One 2012;7:e30457. [PMID: 22291958 DOI: 10.1371/journal.pone.0030457] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Auguste PE, Mistry H, McCarthy ND, Sutcliffe PA, Clarke AE. Cost-effectiveness of testing for latent tuberculosis infection in people with HIV. AIDS 2022;36:1-9. [PMID: 34873091 DOI: 10.1097/QAD.0000000000003060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Uppal A, Rahman S, Campbell JR, Oxlade O, Menzies D. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis. PLoS Med 2021;18:e1003712. [PMID: 34520463 DOI: 10.1371/journal.pmed.1003712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Alsdurf H, Empringham B, Miller C, Zwerling A. Tuberculosis screening costs and cost-effectiveness in high-risk groups: a systematic review. BMC Infect Dis 2021;21:935. [PMID: 34496804 DOI: 10.1186/s12879-021-06633-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Ombura IP, Onyango N, Odera S, Mutua F, Nyagol J. Prevalence of Drug Resistance Mycobacterium Tuberculosis among Patients Seen in Coast Provincial General Hospital, Mombasa, Kenya. PLoS One 2016;11:e0163994. [PMID: 27711122 DOI: 10.1371/journal.pone.0163994] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
5 Diel R, Lampenius N, Nienhaus A. Cost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations. PharmacoEconomics 2015;33:783-809. [DOI: 10.1007/s40273-015-0267-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
6 Houben RM, Dowdy DW, Vassall A, Cohen T, Nicol MP, Granich RM, Shea JE, Eckhoff P, Dye C, Kimerling ME, White RG; TB MAC TB-HIV meeting participants. How can mathematical models advance tuberculosis control in high HIV prevalence settings? Int J Tuberc Lung Dis 2014;18:509-14. [PMID: 24903784 DOI: 10.5588/ijtld.13.0773] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
7 Zwerling A, White RG, Vassall A, Cohen T, Dowdy DW, Houben RM. Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations. PLoS One 2014;9:e110558. [PMID: 25340701 DOI: 10.1371/journal.pone.0110558] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
8 Steuten L, van de Wetering G, Groothuis-oudshoorn K, Retèl V. A Systematic and Critical Review of the Evolving Methods and Applications of Value of Information in Academia and Practice. PharmacoEconomics 2013;31:25-48. [DOI: 10.1007/s40273-012-0008-3] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]